store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brefeldin A (Cyanein) 属于大环内酯类抗生素,是一种 ATPase 抑制剂 (IC50=0.2 μM)。Brefeldin A 可以诱导肿瘤细胞分化和凋亡,也具有抑制自噬的活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 414 | 现货 | ||
10 mg | ¥ 698 | 现货 | ||
50 mg | ¥ 2,470 | 现货 | ||
100 mg | ¥ 3,859 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 414 | 现货 |
产品描述 | Brefeldin A (Cyanein) belongs to the class of macrolide antibiotics and is an ATPase inhibitor (IC50=0.2 μM). Brefeldin A can induce tumor cell differentiation and apoptosis, and also possesses autophagy inhibitory activity. |
靶点活性 | ATPase (HCT 116 cells):0.2 μM |
体外活性 |
方法:肿瘤细胞 HL60 、K562 和 HT-29 用 Brefeldin A (2 μM) 处理 72 h,使用 DNA filter elution assay 检测 DNA 片段。 结果:Brefeldin A 以不同的动力学诱导 DNA 断裂。HL60 细胞在 15 h 内观察到完整的 DNA 片段,而 K562 和 HT-29 细胞则需要 48-72 h。[1] 方法:人乳腺癌细胞 MDA-MB-231 用 Brefeldin A (0.05-1 μg/mL) 处理 24 h,使用 Western Blot 方法检测靶点蛋白表达水平。 结果:PARP 切割是细胞死亡的标志性事件,可以在 Brefeldin A 处理的悬浮 MDA-MB-231 细胞中检测到。[2] |
体内活性 |
方法:为检测体内抗肿瘤活性,将 Brefeldin A (15 mg/kg in 10% ricinus oil+5% DMSO+10% ethanol+75% physiologic saline) 腹腔注射给携带人结直肠癌肿瘤 HCT116 的 BALB/c 小鼠,每天一次,持续四周。 结果:Brefeldin A 在体内抑制 HCT116 肿瘤生长。[3] 方法:为检测体内抗肿瘤活性,将 Brefeldin A (16-64 mg/kg in distilled water containing 0.05% Tween 80) 腹腔注射给携带肿瘤 LOX IMVI 的 Athymic NCr nu/nu 小鼠,每天两次,持续五天。 结果:Brefeldin A 在体内显示出抗肿瘤活性,小鼠寿命增加 65%-100%,第 60 天幸存者增加 17%-50%。[4] |
激酶实验 | ELISA-based active site binding assay: Samples (lysed cells or tissue homogenates) are treated for 1 h at room temperature with the biotinylated active site probe PR-584 (5-15 μM). Samples are denatured by addition of SDS (0.9% final) and heating to 100 °C for 5 min. The denatured samples are transferred to a 96-well or 384-well filter plat, mixed with streptavidin-sepharose beads (2.5-5 μL packed beads/well), and incubated for 1 h at room temperature on a plate shaker. The beads are washed 5 times with 100-200 μL /well of ELISA buffer (PBS, 1% bovine serum albumin, 0.1% Tween-20) by vacuum filtration. The beads are incubated overnight at 4 °C on a plate shaker with the following antibodies recognizing the six catalytic subunits diluted into ELISA buffer: β5, β1, and β2 diluted 1:3000, LMP7 and LMP2 diluted 1:5000, and MECL-1 diluted 1:1000. The beads are washed 5 times with 100-200 μL /well of ELISA buffer and incubated with HRP-conjugated secondary antibody diluted 1:5000 in ELISA buffer and incubated 2 h at room temperature on a plate shaker. The beads are washed 5 times with 100-200 μL /well of ELISA buffer and developed for chemiluminsecence signal using the supersignal ELISA pico substrate following the manufacturer's instructions. Luminescence is measured on a plate reader and converted to ng of proteasome or μg/ml of lysate by comparison with 20S proteasome or untreated cell lysate standard curves. For proteasome inhibitor studies, active site probe binding values are expressed as the percent of binding relative to DMSO treated cells. |
细胞实验 | HF1A3, HF4.9 cell viability upon the treatments is tested using double staining of cells with YO-PRO 1/PI and SYTO16/PI probes. To access cell proliferation, cells are treated with 0–100 ng/mL Brefeldin A in complete medium for 20 hours before adding 1 μCi/mL [methyl-3H]-thymidine for additional 4 hours at 37 °C. The incorporated radioactive thymidine is quantified by scintillation counting with Microbeta counter. To examine long-term effects of Brefeldin A treatment, cells are seeded at initial concentration 105 cells/mL and treated with 0-75 ng/mL Brefeldin A for up to 5 days. At the time indicated, a sample of cells is removed and viable cell number is assessed by standard Trypan Blue exclusion assay.(Only for Reference) |
别名 | BFA, 布雷非德菌素 A, Ascotoxin, Cyanein, Decumbin |
分子量 | 280.36 |
分子式 | C16H24O4 |
CAS No. | 20350-15-6 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2.8 mg/mL (10 mM)
DMSO: 14 mg/mL (50 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 3.5668 mL | 17.8342 mL | 35.6684 mL | 89.1711 mL |
5 mM | 0.7134 mL | 3.5668 mL | 7.1337 mL | 17.8342 mL | |
10 mM | 0.3567 mL | 1.7834 mL | 3.5668 mL | 8.9171 mL | |
DMSO | 20 mM | 0.1783 mL | 0.8917 mL | 1.7834 mL | 4.4586 mL |
50 mM | 0.0713 mL | 0.3567 mL | 0.7134 mL | 1.7834 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Brefeldin A 20350-15-6 Autophagy DNA Damage/DNA Repair Membrane transporter/Ion channel Microbiology/Virology ATPase Mitophagy Antibiotic HSV CRISPR/Cas9 Inhibitor BFA inhibit 布雷非德菌素 A Herpes simplex virus Ascotoxin Mitochondrial Autophagy Cyanein Decumbin inhibitor